Our data demonstrated that high CD123 expression was associated with favorable OS, EFS, and RFS of pediatric B-ALL, especially in patients without prognosis-defining genetic aberrations. The gene discussed is IL3RA; the disease is precursor B-cell acute lymphoblastic leukemia.